Researcher’s Work from Philadelphia Focuses on Opioids (Ingestion of Illicit Substances by Young Children Before and During the COVID-19 Pandemic): Opioids - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
May 8, 2023 Newswires
Share
Share
Post
Email

Researcher’s Work from Philadelphia Focuses on Opioids (Ingestion of Illicit Substances by Young Children Before and During the COVID-19 Pandemic): Opioids

Insurance Daily News

2023 MAY 08 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- New research on opioids is the subject of a new report. According to news reporting originating from Philadelphia, Pennsylvania, by NewsRx correspondents, research stated, “Importance: Information about the trend in illicit substance ingestions among young children during the pandemic is limited. To assess immediate and sustained changes in overall illicit substance ingestion rates among children younger than 6 years before and during the COVID-19 pandemic and to examine changes by substance type (amphetamines, benzodiazepines, cannabis, cocaine, ethanol, and opioids) while controlling for differing statewide medicinal and recreational cannabis legalization policies.”

The news journalists obtained a quote from the research from Division of General Pediatrics: “Design, Setting, and Participants: Retrospective cross-sectional study using an interrupted time series at 46 tertiary care children’s hospitals within the Pediatric Health Information System (PHIS). Participants were children younger than 6 years who presented to a PHIS hospital for an illicit substance(s) ingestion between January 1, 2017, and December 31, 2021. Data were analyzed in February 2023. Exposure: Absence or presence of the COVID-19 pandemic. Main Outcome(s) and Measure(s): The primary outcome was the monthly rate of encounters for illicit substance ingestions among children younger than 6 years defined by International Statistical Classification of Diseases, Tenth Revision, Clinical Modification diagnosis code(s) for poisoning by amphetamines, benzodiazepines, cannabis, cocaine, ethanol, and opioids. The secondary outcomes were the monthly rate of encounters for individual substances. Among 7659 children presenting with ingestions, the mean (SD) age was 2.2 (1.3) years and 5825 (76.0%) were Medicaid insured/self-pay. There was a 25.6% (95% CI, 13.2%-39.4%) immediate increase in overall ingestions at the onset of the pandemic compared with the prepandemic period, which was attributed to cannabis, opioid, and ethanol ingestions. There was a 1.8% (95% CI, 1.1%-2.4%) sustained monthly relative increase compared with prepandemic trends in overall ingestions which was due to opioids.”

According to the news reporters, the research concluded: “There was no association between medicinal or recreational cannabis legalization and the rate of cannabis ingestion encounters. Conclusions and Relevance: In this study of illicit substance ingestions in young children before and during the COVID-19 pandemic, there was an immediate and sustained increase in illicit substance ingestions during the pandemic. Additional studies are needed to contextualize these findings in the setting of pandemic-related stress and to identify interventions to prevent ingestions in face of such stress, such as improved parental mental health and substance treatment services, accessible childcare, and increased substance storage education.”

For more information on this research see: Ingestion of Illicit Substances by Young Children Before and During the COVID-19 Pandemic. JAMA Network Open, 2023,6(4). (JAMA Network Open - https://jamanetwork.com/journals/jamanetworkopen). The publisher for JAMA Network Open is American Medical Association (AMA).

A free version of this journal article is available at https://doi.org/10.1001/jamanetworkopen.2023.9549.

Our news editors report that additional information may be obtained by contacting M. Katherine Henry, Safe Place: Center for Child Protection and Health, Division of General Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States. Additional authors for this research include Brittany J. Raffa, Samantha Schilling, Victor Ritter, Colleen E. Bennett, Jeannie S. Huang, Natalie Laub.

(Our reports deliver fact-based news of research and discoveries from around the world.)

Older

Researchers Submit Patent Application, “Remote Diagnostic Testing Systems And Methods”, for Approval (USPTO 20230121265): Patent Application

Newer

“Methods And Systems For Anonymizing Genome Segments And Sequences And Associated Information” in Patent Application Approval Process (USPTO 20230124077): Patent Application

Advisor News

  • Retirement providers turn to digital engagement to retain assets
  • Looking out for clients with diminished mental capacity
  • House panel advances CLEAR Forms Act backed by IRI
  • Modifying life insurance based on evolving needs
  • Gen X faces ‘pension envy’ as they head into retirement
More Advisor News

Annuity News

  • Global Atlantic Announces Launch of ForeLifetime Income, a New Fixed Index Annuity
  • A-Cap strikes back with lawsuit accusing SC regulators of sloppy process, leaking secrets
  • AM Best to Discuss Its Views on Private Credit Surge and Risks at 2026 NAIC/NIPR Insurance Summit
  • OID recovers $260M in life insurance benefits
  • NUNN BILLS TO COMBAT PAYMENT SCAMS, CUT FINANCIAL RED TAPE PASS FINANCIAL SERVICES COMMITTEE
More Annuity News

Health/Employee Benefits News

  • Pennsylvanians buying 2027 health insurance on Pennie will face 16% average premium increase
  • Putting a price on preventive care: How Medicaid compares to other insurers in Virginia: George Mason University
  • Researchers from State University of New York (SUNY) Buffalo Provide Details of New Studies and Findings in the Area of Artificial Intelligence (An Informatics Framework To Harmonize Electronic Health Record Medication Data for Managed Care …): Artificial Intelligence
  • Studies from University of Rhode Island Have Provided New Data on Artificial Intelligence (Who Is Responsible? a Risk-stratified Framework for Pharmacist Accountability In Artificial Intelligence-assisted Managed Care): Artificial Intelligence
  • Researchers from Yale University School of Medicine Describe Findings in Managed Care (Trends in CT Angiography of the Head and Neck, 2017-2024: Provider Volume, Specialty Distribution, and Workforce Implications): Managed Care
Sponsor
More Health/Employee Benefits News

Life Insurance News

  • Insurance Life Is Uncertain Get Life Insurance
  • Judge OKs class action against State Farm over PHL life insurance policies
  • AM Best Assigns Credit Ratings to Lasso Healthcare Insurance Company
  • A-Cap insurers face new takeover push in South Carolina
  • AM Best Affirms Credit Ratings and Assigns National Scale Rating to Allianz Ayudhya General Insurance Public Company Limited
Sponsor
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Lauren Sinnott Named to Ragan’s Top Women in Marketing Awards, Class of 2026 
  • Classic Car Insurer OpenRoad Insurance Expands to 40 U.S. States in Two Years
  • How Aspire General Turned an Early Technology Bet Into Claims Automation at Scale with Kyber
  • Adjusto launches AI-Native contents claims services powered by its technology platform
  • URL Insurance Group Celebrates 40 Years of Service, Growth, and Industry Leadership
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.